Advertisement

Ads Placeholder
Loading...

Rockwell Medical, Inc.

RMTINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.96
$0.02(2.54%)
U.S. Market opens in 0h 44m

Rockwell Medical, Inc. (RMTI) Stock Overview

Explore Rockwell Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap37.7M
P/E Ratio-7.10
EPS (TTM)$-0.15
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$1.08
3 Months$1.14
1 Year Target$0.00

RMTI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Rockwell Medical, Inc. (RMTI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.10 and a market capitalization of 37.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.54%
5-Day Change
2.91%
1-Month Change
6.39%
3-Month Change
10.84%
6-Month Change
-21.57%
Year-to-Date (YTD) Change
10.84%
1-Year Change
-6.19%
3-Year Change
-46.84%
5-Year Change
-92.02%
All-Time (Max) Change
-98.30%

Contact Information

248 960 9009
30142 South Wixom road, Wixom, MI, 48393

Company Facts

2,440 Employees
IPO DateJan 27, 1998
CountryUS
Actively Trading

Frequently Asked Questions